Literature DB >> 18318116

[Association of polymorphous markers Pro72Arg and C(-594)CC OF TP53 gene with diabetic polyneuropathy in patients with type 1 diabetes mellitus living in Moscow].

E V Spitsina, N Iu Iakunina, D A Chudakova, A G Nikitin, G N Svetlova, T N Soluianova, I A Strokov, V V Nosikov.   

Abstract

The aim of this study was the search of association of polymorphous markers Pro72Arg and C(-594)CC of TP53 gene with diabetic polyneuropathy (DPN) in patients with type 1 diabetes mellitus with or without clinical signs of DPN. We have found that polymorphous marker Pro72Arg of TP53 gene was associated with DPN in Russian patients with type 1 diabetes mellitus living in Moscow. The carriers of Arg allele and Arg/Arg genotype had higher risk of DPN development (OR = 1.96; CI = 1.32-2.90; and OR = 2.14; CI = 1.23-3.73; relatively). On the contrary, the carriage of Pro allele was associated with the lower risk of DPN development (OR = 0.51; CI = 0.34-0.76). We have not found any association of polymorphous marker C(-594)CC of TP53 gene with DPN in Russian patients with type 1 diabetes mellitus living in Moscow.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18318116

Source DB:  PubMed          Journal:  Mol Biol (Mosk)        ISSN: 0026-8984


  9 in total

1.  Molecular network-based analysis of guizhi-shaoyao-zhimu decoction, a TCM herbal formula, for treatment of diabetic peripheral neuropathy.

Authors:  Ning Zhao; Jian Li; Li Li; Xu-yan Niu; Miao Jiang; Xiao-juan He; Zhao-xiang Bian; Ge Zhang; Ai-ping Lu
Journal:  Acta Pharmacol Sin       Date:  2015-04-27       Impact factor: 6.150

Review 2.  The role of the p53 tumor suppressor in metabolism and diabetes.

Authors:  Che-Pei Kung; Maureen E Murphy
Journal:  J Endocrinol       Date:  2016-09-09       Impact factor: 4.286

3.  [Colorectal cancer 2D-proteomics: identification of altered protein expression].

Authors:  G S Krasnov; N Iu Oparina; S L Khankin; T D Mashkova; A N Ershov; O G Zatsepina; V L Karpov; S F Beresten'
Journal:  Mol Biol (Mosk)       Date:  2009 Mar-Apr

Review 4.  Is p53 Involved in Tissue-Specific Insulin Resistance Formation?

Authors:  Justyna Strycharz; Jozef Drzewoski; Janusz Szemraj; Agnieszka Sliwinska
Journal:  Oxid Med Cell Longev       Date:  2017-01-17       Impact factor: 6.543

Review 5.  Emerging Roles of p53 Family Members in Glucose Metabolism.

Authors:  Yoko Itahana; Koji Itahana
Journal:  Int J Mol Sci       Date:  2018-03-08       Impact factor: 5.923

6.  Associations of TP53 codon 72 polymorphism with complications and comorbidities in patients with type 1 diabetes.

Authors:  Bartosz Słomiński; Maria Skrzypkowska; Monika Ryba-Stanisławowska; Małgorzata Myśliwiec; Piotr Trzonkowski
Journal:  J Mol Med (Berl)       Date:  2021-01-25       Impact factor: 4.599

7.  Relationship between TP53 and interleukin-6 gene variants and the risk of types 1 and 2 diabetes mellitus development in the Kermanshah province.

Authors:  Lida Haghnazari; Ramin Sabzi
Journal:  J Med Life       Date:  2021 Jan-Mar

8.  Network Pharmacology and Molecular Docking Study on the Potential Mechanism of Yi-Qi-Huo-Xue-Tong-Luo Formula in Treating Diabetic Peripheral Neuropathy.

Authors:  Yixuan Lin; Chuqiao Shen; Fanjing Wang; Zhaohui Fang; Guoming Shen
Journal:  J Diabetes Res       Date:  2021-05-28       Impact factor: 4.011

9.  Hp1-1 as a Genetic Marker Regulating Inflammation and the Possibility of Developing Diabetic Complications in Patients with Type 2 Diabetes-Cohort Studies.

Authors:  Anna Stempkowska; Magdalena Walicka; Edward Franek; Marek Naruszewicz; Mariusz Panczyk; Yarsolav Sanchak; Agnieszka Filipek
Journal:  Genes (Basel)       Date:  2020-10-24       Impact factor: 4.096

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.